BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25890890)

  • 1. Malignant ovarian Brenner tumor. A case report evaluated with (18)F-FDG PET/CT.
    Mena LM; Carmona E; Maza FR; Guiote MV; Moreno E; Vallejo JA
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):337-8. PubMed ID: 25890890
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastrointestinal stromal tumour with unusual sites of metastasis: accurate staging with ¹⁸F-FDG PET/CT.
    Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):60-1. PubMed ID: 25263720
    [No Abstract]   [Full Text] [Related]  

  • 3. FDG PET/CT of a benign ovarian Brenner tumor.
    Toriihara A; Taniguchi Y; Negi M; Kubota K; Makino T; Shibuya H
    Clin Imaging; 2012; 36(5):650-3. PubMed ID: 22920385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT].
    Moragas M; Soler M; Riera E; García JR
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic small cell neuroendocrine carcinoma of the pyriform sinus evaluated by ¹⁸F-FDG PET/CT.
    Treglia G; Bongiovanni M; Paone G; Ruberto T; Parvex-Leoni S; Giovanella L
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):125-7. PubMed ID: 25018134
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebellar hypermetabolism on ¹⁸F-FDG PET/CT with normal MRI in a case of paraneoplastic cerebellar degeneration with negative antibodies.
    Sharma P; Mazumdar B; Chatterjee P
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):79-80. PubMed ID: 25001850
    [No Abstract]   [Full Text] [Related]  

  • 8. Atypical location of metastatic ovarian carcinoma detected by (18)F-FDG PET/CT.
    Sagasta Urrutia J; Portilla-Quattrociocchi H; Garcia Hernandez D; Montero de la Peña A; Moreno Capdevila C; Tobalina Larrea I
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):58-60. PubMed ID: 26341423
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
    Mittal BR; Manohar K; Kashyap R; Bhattacharya A; Singh B; Singh G
    Hell J Nucl Med; 2011; 14(2):135-9. PubMed ID: 21761015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging and evaluation of neoadjuvant chemotherapy response with ¹⁸F-FDG PET/CT in NUT-midline carcinoma in a child: a case report and review of the literature.
    Ciftci E; Demirsoy U; Anik Y; Gorur G; Corapcioglu F; Demir H
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):53-5. PubMed ID: 25304847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
    Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PET/CT scan with (18)F-FDG in re-staging of an atypical case of ovarian cancer].
    García Gómez FJ; Cuenca Cuenca JI; Acevedo Báñez I; Borrego Dorado I; Calvo García E; Vázquez Albertino RJ
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):223-4. PubMed ID: 23067691
    [No Abstract]   [Full Text] [Related]  

  • 13. FDG-PET/CT of Vulvar Adenocarcinoma With Diffuse Metastases.
    Patel D; Anderson TM; Lu Y
    Clin Nucl Med; 2016 Sep; 41(9):710-1. PubMed ID: 27187733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy.
    Tawakol A; Abdelhafez YG; Osama A; Hamada E; El Refaei S
    Nucl Med Commun; 2016 May; 37(5):453-60. PubMed ID: 26745811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare case of anaplastic large T-cell lymphoma of the lung evaluated by ¹⁸F-FDG PET/CT.
    Treglia G; Barizzi J; Bongiovanni M; Vannata B; Ceriani L; Giovanella L
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):139-40. PubMed ID: 25103142
    [No Abstract]   [Full Text] [Related]  

  • 16. Uterine leiomyosarcoma metastatic to thyroid shown by
    Gauthé M; Testart Dardel N; Nascimento C; Trassard M; Banal A; Alberini JL
    Rev Esp Med Nucl Imagen Mol; 2017; 36(2):113-115. PubMed ID: 27777040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
    Lin XP; Zhao C; Chen MY; Fan W; Zhang X; Zhi SF; Liang PY
    Ai Zheng; 2008 Sep; 27(9):974-8. PubMed ID: 18799039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mesothelioma staging with ¹⁸F-FDG PET/CT. A case report with simultaneous pleural and peritoneal infiltration].
    Moreno C; Soler M; Mourelo S; Moragas M; Riera E; Garcia JR
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):141-2. PubMed ID: 25049160
    [No Abstract]   [Full Text] [Related]  

  • 20. ¹⁸F-FDG PET/CT imaging in blow-out metastases of clavicle from carcinoma of urinary bladder.
    Mukherjee A; Karunanithi S; Singla S; Agarwal KK; Kumar A; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):136-8. PubMed ID: 25444393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.